Enzon Pharmaceuticals Inc.
Enzon Pharmaceuticals Inc.
Enzon Pharmaceuticals Inc.
Overview
Date Founded
Headquarters
Type of Company
Employees (Worldwide)
Industries
Company Description
Website
Contact Data
In The News
GlobeNewswire
January 4, 2021
SEC
November 9, 2020
GlobeNewswire
October 21, 2020
RelSci
August 13, 2020
RelSci
August 13, 2020
Executives & Employees
Chief Executive Officer & Secretary
Chief Executive Officer
Principal Financial Officer
Head of R&D
Director
Associate Director Quality Assurance
Associate Director Engineering
Network Administrator
Principal Financial Officer
Vice President
Board of Directors
President & Chief Executive Officer at Nevada Strategic Credit Investments LLC
Vice President/Taxes at The Icahn Medical Research Foundation
Vice President of Investor Relations & Strategy at Calithera Biosciences, Inc.


Owners & Shareholders



Recent Transactions



Transaction Advisors
Investment Advisor
Accountant
Underwriter
Advisors & Consultants
Clients
Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
Net Profit
EBITDA
EBITDAMargin
Total Debt
Total Equity
Enterprise Value / Sales
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
Non-Profit Donations & Grants
$10K - $50K
2011
$50K - $100K
2010
$10K - $50K
2010
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Enzon Pharmaceuticals Inc.. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Enzon Pharmaceuticals Inc.'s profile does not indicate a business or promotional relationship of
any kind between RelSci and Enzon Pharmaceuticals Inc..